ANI Pharmaceuticals, Inc. (ANIP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.58B |
| Enterprise Value | 1.62B |
| P/E Ratio | 20.18 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 2.04 |
| Price/Book Ratio | 3.08 |
| Enterprise/Revenue | 2.06 |
| Enterprise/EBITDA | 8.1 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.1 |
| Operating Margin | 0.13 |
| Return On Assets | 0.06 |
| Return On Equity | 0.17 |
| Revenue | 883.37M |
| Revenue/Share | 44.17 |
| Gross Profit | 450.64M |
| EBITDA | 207.27M |
| Net Income | 78.34M |
| Diluted EPS | 3.32 |
| Total Cash | 311.18M |
| Total Cash/Share | 14.88 |
| Total Debt | 327.76M |
| Total Debt/Equity | 0.58 |
| Current Ratio | 3.12 |
| Book Value Per Share | 26.89 |
| 52-Week Change | 25.61 |
| 52-Week High | 99.5 |
| 52-Week Low | 62.61 |
| Moving Average 50 Days | 80.15 |
| Moving Average 200 Days | 82.99 |
| Average Volume | 343,532 |
| Shares Outstanding | 22.73M |
| % Held by Institutions | 116.63 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0.01 |
| Last Split Factor | 1:6 |
| Last Split Date | July 18, 2013 |